Explore › Outcome › Plasma HDL cholesterol measurement
Outcome

Plasma HDL cholesterol measurement

Also known as: Plasma HDL cholesterol level Plasma HDL cholesterol level (procedure) Plasma HDL cholesterol levels over 12 weeks Plasma HDL cholesterol measurement Plasma HDL cholesterol measurement (procedure) Plasma high density lipoprotein cholesterol measurement Plasma high density lipoprotein cholesterol measurement (procedure) HDL
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
Anti-miR-33 antisense oligonucleotide1
conditions
Dyslipidemia1
studys
PMC32355841

Findings (27)

None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →
None
improvement

Systemic delivery of anti-miR-33 in African green monkeys induced a sustained 50% increase in plasma HDL cholesterol over 12 weeks, with corresponding increases in HDL-associated apolipoproteins AI an

Effect: improvement; 50% increase in HDL cholesterol at 8 weeks, sustained through 12 weeks

Size: 50% increase in HDL cholesterol at 8 weeks, sustained throug
PMC3235584
Finding details → · Paper → · Graph →

Papers (1)